Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan

Ko Ko1, Kazuaki Takahashi1, Shintaro Nagashima1

  • 1Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Scientific Reports
|February 15, 2022
PubMed

Related Concept Videos